Tirzepatide

Tirzepatide for Sale: Research-Grade GIP/GLP-1 Dual Agonist for Metabolic Studies

Researchers who need tirzepatide for sale often face a sourcing dilemma. Furthermore, international suppliers ship from overseas cold-storage facilities that expose peptides to customs delays and temperature excursions. Consequently, Pure Peptide Factory solves that problem. We stock research-grade tirzepatide domestically, ship same-day with phase-change cooling, and deliver to your laboratory within 1 to 3 business days.

Moreover, tirzepatide is a 39-amino acid linear peptide and the first dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. If your protocol investigates incretin biology, beta cell function, or multi-pathway metabolic regulation, this compound belongs in your peptide panel.

Why Researchers Buy Tirzepatide for Sale from Pure Peptide Factory

Domestic Cold-Chain Protects Every Vial of Tirzepatide for Sale

Peptides of this size and complexity degrade rapidly when exposed to temperature fluctuations. Furthermore, researchers searching for tirzepatide for sale are not merely looking for convenience. They need a compound that arrives with intact tertiary structure and verified purity. We ship from domestic cold-storage using phase-change cooling technology. Consequently, your vial arrives within 72 hours at the temperature it left the freezer.

Documentation That Satisfies Institutional Compliance

Every order ships with a lot-specific HPLC chromatogram, mass spectrometry report, and Certificate of Analysis. Additionally, synthesis logs are archived for 24 months. If your IRB or compliance office requests chain-of-custody documentation, you download it before your compound even arrives.

Multiple Vial Configurations for Protocol Flexibility

We stock tirzepatide in 5mg, 10mg, 15mg, and 20mg vials. Moreover, researchers running dose-response studies or long-duration metabolic protocols can source all configurations from a single supplier. No need to reconcile batch numbers across multiple vendors.

Run Head-to-Head Comparisons Without Batch Variables

Many research protocols compare tirzepatide against semaglutide, retatrutide, or liraglutide. Therefore, sourcing all compounds from one supplier eliminates batch-to-batch variability as a confounding factor. We stock the full incretin agonist panel in the same cold-storage facility under identical handling protocols.

What Is Tirzepatide?

The First Dual GIP/GLP-1 Receptor Agonist

Tirzepatide is a synthetic 39-amino acid peptide that represents a new class of metabolic research compounds. Moreover, it activates both the GIP receptor and the GLP-1 receptor with high affinity, producing synergistic effects on glucose homeostasis, appetite regulation, and lipid metabolism that exceed what either pathway achieves alone. Ultimately, Eli Lilly developed this molecule under the designation LY3298176.

Molecular Profile:

• Molecular Formula: C225H348N56O68
• Molecular Weight: 4813.45 g/mol
• Sequence: 39-amino acid linear peptide with two aminoisobutyric acid (Aib) substitutions at positions 2 and 13 for protease resistance, plus a C20 fatty diacid moiety conjugated via a hydrophilic linker for albumin binding
• CAS: 2023788-19-2 (Tirzepatide acetate)
• Synonyms: LY3298176, GIP/GLP-1 dual agonist, Mounjaro (FDA drug name), Zepbound (FDA drug name), Tirzepatide research peptide

Structural Engineering for Extended Half-Life

Tirzepatide incorporates two critical modifications that distinguish it from native incretin hormones. First, aminoisobutyric acid (Aib) residues replace alanine at positions 2 and 13, conferring resistance to dipeptidyl peptidase-4 (DPP-4) degradation. Second, a C20 fatty diacid chain attaches via a gamma-Glu-2xOEG linker, promoting reversible albumin binding. Consequently, the peptide achieves a half-life of approximately 116 to 120 hours, enabling once-weekly administration research paradigms. Ultimately, researchers who buy tirzepatide for sale for chronic protocols benefit from this extended pharmacokinetic profile.

Mechanism of Action: Dual Incretin Pathway Activation

Tirzepatide binds with high affinity to both GIP and GLP-1 receptors on pancreatic beta cells, gastric enteroendocrine cells, hypothalamic neurons, and adipose tissue macrophages. This dual binding triggers multiple downstream effects.

More specifically, GIP receptor activation enhances glucose-dependent insulin secretion and promotes lipid clearance in adipose tissue. GLP-1 receptor activation suppresses postprandial glucagon release, delays gastric emptying through vagal afferent signaling, and reduces food intake via central hypothalamic satiety pathways. Furthermore, the combination produces additive body weight reduction and superior glycemic control compared to selective GLP-1 agonism alone.

Research published in The New England Journal of Medicine demonstrates that tirzepatide reduces HbA1c by up to 2.58 percent and produces mean body weight reductions of 15 to 22.5 percent in phase 3 clinical models. Rosenstock et al., SURPASS-4 trial, NEJM 2022

FDA History and Clinical Context

The FDA approved tirzepatide in November 2022 under the trade name Mounjaro for the treatment of type 2 diabetes in adults. In November 2023, the FDA approved the same molecule under the trade name Zepbound for chronic weight management. These approvals were based on the SURPASS and SURMOUNT clinical trial programs, which collectively enrolled over 15,000 participants across multiple phase 3 studies.

However, the research-grade tirzepatide peptide available from Pure Peptide Factory is not the commercial Mounjaro or Zepbound formulation. Specifically, it is synthesized for laboratory research and is sold strictly under research-use-only terms. Therefore, researchers studying incretin pharmacology, metabolic disease models, or peptide engineering benefit from access to the pure compound independent of the commercial drug supply chain.

Tirzepatide Research Applications

Type 2 Diabetes and Glycemic Control

Tirzepatide lowers fasting and postprandial glucose through multiple complementary mechanisms. Importantly, it enhances first-phase and second-phase insulin secretion in a glucose-dependent manner, meaning insulin release only occurs when blood glucose is elevated. Additionally, it suppresses inappropriate postprandial glucagon secretion, which reduces hepatic glucose output. Ultimately, researchers buy tirzepatide for sale to study incretin-based therapies, beta cell responsiveness, and novel approaches to insulin resistance. Frías et al., SURPASS-2 trial vs Semaglutide, NEJM 2021

Obesity and Body Composition

The SURMOUNT clinical program demonstrated that tirzepatide produces dose-dependent weight loss exceeding that of any previously approved anti-obesity pharmacotherapy. Notably, at the 15mg dose, participants achieved mean weight reductions of 22.5 percent over 72 weeks. Moreover, the peptide reduces visceral adipose tissue, improves waist circumference, and favorably shifts body composition toward lean mass preservation. Consequently, researchers buy tirzepatide for sale to investigate metabolic flexibility, energy expenditure protocols, and central appetite regulation. Aronne et al., SURMOUNT-1, NEJM 2022

Cardiovascular Protection and Endothelial Function

Emerging preclinical data suggests tirzepatide offers cardiovascular benefits beyond weight loss and glycemic control. Specifically, the peptide reduces inflammatory cytokine production in vascular endothelium, improves nitric oxide bioavailability, and attenuates atherosclerotic plaque progression in animal models. Furthermore, the SELECT-like cardiovascular outcomes data for GLP-1 agonists supports investigation of whether dual GIP/GLP-1 activation provides superior cardioprotection. Ultimately, researchers studying diabetic cardiomyopathy, endothelial dysfunction, or post-infarct remodeling incorporate tirzepatide into their cardiovascular peptide panels.

NAFLD and NASH

Non-alcoholic fatty liver disease and its progressive form NASH represent major unmet medical needs. Tirzepatide reduces hepatic steatosis through multiple pathways: decreased de novo lipogenesis, increased fatty acid oxidation, reduced hepatic insulin resistance, and weight-loss-mediated decreases in visceral fat drainage to the liver. Consequently, researchers investigating metabolic liver disease use tirzepatide to study hepatic lipid clearance, fibrosis regression, and the interaction between adipose tissue inflammation and liver pathology.

Beta Cell Preservation and Proliferation

GIP and GLP-1 receptor signaling both promote beta cell survival, reduce apoptosis, and stimulate neogenesis in preclinical models. Furthermore, tirzepatide amplifies these effects through dual receptor activation. Additionally, the peptide improves beta cell glucose sensitivity and restores first-phase insulin secretion in diabetic models. Ultimately, for researchers studying islet biology, autoimmune diabetes, or regenerative endocrinology, tirzepatide provides a tool to investigate whether dual incretin agonism can preserve or restore functional beta cell mass.

Tirzepatide vs Semaglutide Head-to-Head Research

The SURPASS-2 trial provided the first direct comparison of tirzepatide against semaglutide 1mg in type 2 diabetes. Importantly, tirzepatide demonstrated superior HbA1c reduction and greater weight loss across all doses. Therefore, many research protocols now design direct comparison studies between these two molecules to isolate the contribution of GIP receptor agonism. Ultimately, we stock both tirzepatide and semaglutide for researchers running parallel-arm comparison protocols from a single supplier.

Tirzepatide vs Semaglutide vs Retatrutide: Choosing the Right Incretin Agonist

Feature	Tirzepatide	Semaglutide	Retatrutide
Receptor Targets	GIP + GLP-1	GLP-1 only	GIP + GLP-1 + GCG
Amino Acid Length	39	31	39
Half-Life	~116-120 hours	~165 hours	~120-140 hours
Dosing Frequency	Once weekly	Once weekly	Once weekly
Weight Loss (Phase 3)	Up to 22.5%	Up to 15%	Up to 24.2%
HbA1c Reduction	Up to 2.58%	Up to 1.8%	Up to 2.02%
Primary Research Use	Dual incretin synergy, metabolic disease	Selective GLP-1 pathway	Triple agonist, maximal metabolic effect
FDA Status	Approved 2022 (Mounjaro), 2023 (Zepbound)	Approved 2017 (Ozempic), 2021 (Wegovy)	Phase 3 (not yet approved)
Best For Studying	GIP contribution to GLP-1 effects	Pure GLP-1 mechanism	Glucagon addition to dual agonism

When Tirzepatide Is the Right Choice

Choose tirzepatide when your protocol requires investigation of dual incretin synergy. Furthermore, its FDA-approved status provides extensive human safety and efficacy reference data that purely experimental peptides lack. The GIP component adds lipid metabolism effects and superior weight loss compared to selective GLP-1 agonism.

When Semaglutide or Retatrutide May Be More Appropriate

Semaglutide remains the gold standard for isolating pure GLP-1 receptor effects without GIP cross-talk. Retatrutide, on the other hand, adds glucagon receptor agonism to the dual incretin foundation, producing even greater weight loss and energy expenditure in early-phase research. All three peptides are available from Pure Peptide Factory for direct comparison and combination studies.

How to Reconstitute Tirzepatide

Standard Laboratory Protocol

1. Sanitize the vial stopper with 70% isopropyl alcohol.
2. Inject bacteriostatic water slowly against the vial wall. Do not direct the stream at the lyophilized cake.
3. Allow the cake to dissolve without agitation for 3 to 5 minutes. Tirzepatide is a large peptide and requires patience.
4. Gently swirl until the solution is fully clear. Do not shake vigorously.
5. Inspect for clarity. Discard if particulate matter remains.

Concentration Reference by Vial Size

Vial Size	Bacteriostatic Water	Final Concentration
5mg + 1mL	1mL	5mg/mL
5mg + 2mL	2mL	2.5mg/mL
10mg + 2mL	2mL	5mg/mL
15mg + 3mL	3mL	5mg/mL
20mg + 4mL	4mL	5mg/mL

Adjust reconstitution volume to achieve the concentration required for your specific research model. Because tirzepatide has a half-life of approximately 116 to 120 hours, timing of administration in chronic protocols is typically once weekly.

Storage Requirements

• Lyophilized powder: 24 months at -20°C, protected from light.
• Reconstituted solution: 28 days at 2 to 8°C. Do not freeze.
• Protect from light at all stages. The peptide contains photosensitive aromatic residues.

Tirzepatide for Sale: Regulatory and Safety Context

Research Use Only Status

Tirzepatide received FDA approval in 2022 and 2023 for human therapeutic use under the brand names Mounjaro and Zepbound. However, the research-grade tirzepatide peptide available from Pure Peptide Factory is a separate category. Specifically, it is synthesized for laboratory research and is sold strictly under research-use-only terms. Consequently, it is not intended for human consumption, veterinary use, or diagnostic application. Ultimately, all purchasers must agree to research-use-only terms at checkout.

Is Tirzepatide Safe for Research Models?

Published clinical data from over 15,000 participants across the SURPASS and SURMOUNT programs provides an extensive safety reference for GIP/GLP-1 dual agonism. Notably, the most common adverse effects observed were gastrointestinal in nature: nausea, diarrhea, and constipation. Furthermore, preclinical rodent and non-human primate data support a favorable safety profile for metabolic research applications. Ultimately, as with all research compounds, institutional biosafety protocols and IRB approval are required for in vivo work.

Why Researchers Source Tirzepatide Domestically

International peptide shipments face customs scrutiny, temperature excursions, and unpredictable delivery timelines. Furthermore, when you search for tirzepatide for sale or where to buy tirzepatide, you need a domestic source that protects both your compound and your research schedule. Ultimately, we provide that assurance with same-day dispatch and verified cold-chain integrity.

Product Specifications

Available Vial Configurations

Tirzepatide is available in 5mg, 10mg, 15mg, and 20mg vials. Furthermore, select the configuration that matches your protocol from the product selector above.

Quality Verification

Furthermore, every batch of tirzepatide for sale meets the following quality standards:

• Purity: 98% minimum (HPLC verified)
• Identity: Mass spectrometry confirmed
• Endotoxin: Less than 0.1 EU/mL
• Sterility: Verified per USP <71>
• Form: Lyophilized powder (acetate salt)
• Storage: -20°C long-term, 2 to 8°C short-term
• Current Batch: #PPF-TIRZ-0426
• Purity: 98.7%
• Download: HPLC Certificate | MS Report

Frequently Asked Questions

What is tirzepatide peptide used for in research? Tirzepatide for sale

Specifically, tirzepatide is used to study dual GIP/GLP-1 receptor agonism, type 2 diabetes models, obesity and body composition, cardiovascular protection, NAFLD/NASH, beta cell preservation, and direct comparisons against semaglutide and retatrutide.

Where can I find tirzepatide for sale?

Pure Peptide Factory stocks research-grade tirzepatide for sale domestically. Furthermore, orders ship same-day with cold-chain packaging and arrive within 1 to 3 business days. No prescription required for laboratory procurement under research-use-only terms.

How does tirzepatide compare to semaglutide?

Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide is a selective GLP-1 agonist. Consequently, tirzepatide produces greater weight loss and HbA1c reduction in head-to-head trials. Researchers choose tirzepatide to study dual incretin synergy and choose semaglutide to isolate pure GLP-1 effects.

How does tirzepatide compare to retatrutide?

Retatrutide adds glucagon receptor agonism to the GIP/GLP-1 dual mechanism, making it a triple agonist. However, retatrutide shows slightly greater weight loss in early trials, but tirzepatide has far more published clinical data and an established FDA approval history.

What is the best place to buy tirzepatide?

Pure Peptide Factory offers domestic cold-chain shipping, lot-specific HPLC and MS documentation, and multiple vial sizes. Furthermore, every order includes a Certificate of Analysis and ships within 1 to 3 business days.

Is tirzepatide FDA approved?

Yes, tirzepatide is FDA approved as Mounjaro for type 2 diabetes and Zepbound for weight management. However, the research-grade peptide sold here is a separate laboratory compound for research use only.

What vial sizes are available?

We stock tirzepatide in 5mg, 10mg, 15mg, and 20mg vials. Additionally, select your size from the product selector above.

How should I store reconstituted tirzepatide?

Store reconstituted solution at 2 to 8°C and use within 28 days. Furthermore, do not freeze. Ultimately, protect from light at all stages.

Can I buy tirzepatide without a prescription?

Yes, for research purposes under research-use-only terms. Specifically, this is laboratory procurement, distinct from the FDA-approved commercial drug.

Do you ship tirzepatide to my state?

We ship research-grade peptides to all 50 states from domestic cold-storage. Furthermore, orders placed before 2 PM EST ship same-day.

What is the molecular weight of tirzepatide?

Tirzepatide has a molecular weight of approximately 4813.45 g/mol. Furthermore, the exact mass is confirmed on the Certificate of Analysis shipped with each order.

Can tirzepatide be combined with other peptides in research?

Yes. Specifically, many researchers study tirzepatide alongside semaglutide, retatrutide, or metabolic peptides like MOTS-c and AOD9604. Ultimately, we stock the full metabolic research panel for comparison protocols.

Buy Tirzepatide for Sale for Your Research

Secure Checkout

• Credit card, cryptocurrency, or wire transfer
• Same-day dispatch for orders placed before 2 PM EST
• Cold-chain packaging with phase-change cooling
• Discreet labeling with full tracking

Institutional Accounts

Net-30 terms and purchase order acceptance available for universities and research institutions. Furthermore, contact us for bulk pricing on 50 vials or more.

Add to cart and secure tirzepatide for sale today for your metabolic research.